Target
Vascular endothelial growth factor A
Ligand
BDBM282727
Substrate
n/a
Meas. Tech.
Scintillation Proximity Assay (SPA)
pH
7.5±n/a
IC50
17600±n/a nM
Comments
extracted
Citation
 Dixon, DDGrina, JJosey, JARizzi, JPSchlachter, STWallace, EMWang, BWehn, PXu, RYang, H Cyclic sulfone and sulfoximine analogs and uses thereof US Patent  US9884843 Publication Date 2/6/2018 
Target
Name:
Vascular endothelial growth factor A
Synonyms:
VEGF | VEGF-A | VEGFA | VEGFA_HUMAN | VPF | Vascular endothelial growth factor (VEGF) | Vascular endothelial growth factor A (VEGF) | Vascular endothelial growth factor A (VEGF2) | Vascular permeability factor
Type:
Protein
Mol. Mass.:
27063.81
Organism:
Homo sapiens (Human)
Description:
P15692
Residue:
232
Sequence:
MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR
  
Inhibitor
Name:
BDBM282727
Synonyms:
US9884843, Compound 71
Type:
Small organic molecule
Emp. Form.:
C14H8F2O4S
Mol. Mass.:
310.273
SMILES:
Fc1cc(F)cc(Oc2ccc3c(c2)C(=O)CS3(=O)=O)c1
Structure:
Search PDB for entries with ligand similarity: